Literature DB >> 21253967

Brain-derived neurotrophic factor in human saliva: ELISA optimization and biological correlates.

Abigail L Mandel1, Hakan Ozdener, Virginia Utermohlen.   

Abstract

In order to assess the physiological significance of human salivary brain-derived neurotrophic factor (BDNF), we have optimized a sensitive and specific enzyme-linked immunosorbent assay (ELISA). We determined the range of salivary BDNF concentrations, the impact of saliva collection method, and the association of salivary BDNF with several biological characteristics. The ELISA had a detection limit of 62.5 pg/mL, and intra-assay and interassay precisions of 4.2% and 8.2%, respectively. Salivary BDNF concentrations were highly variable between individuals (median = 618 pg/mL) and were affected by collection method. Women had significantly higher levels of salivary BDNF than men. There was no relationship, however, between salivary BDNF levels and the other biological characteristics examined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253967      PMCID: PMC3046426          DOI: 10.1080/15321819.2011.538625

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  28 in total

1.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Regulation of cell survival by secreted proneurotrophins.

Authors:  R Lee; P Kermani; K K Teng; B L Hempstead
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

3.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

Authors:  Félicien Karege; Guillaume Perret; Guido Bondolfi; Michèle Schwald; Gilles Bertschy; Jean-Michel Aubry
Journal:  Psychiatry Res       Date:  2002-03-15       Impact factor: 3.222

4.  Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results.

Authors:  E A Shirtcliff; D A Granger; E Schwartz; M J Curran
Journal:  Psychoneuroendocrinology       Date:  2001-02       Impact factor: 4.905

5.  The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

Authors:  Maria Neves-Pereira; Emanuela Mundo; Pierandrea Muglia; Nicole King; Fabio Macciardi; James L Kennedy
Journal:  Am J Hum Genet       Date:  2002-08-02       Impact factor: 11.025

6.  Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders.

Authors:  Michiko Nakazato; Kenji Hashimoto; Eiji Shimizu; Chikara Kumakiri; Hiroki Koizumi; Naoe Okamura; Makoto Mitsumori; Naoya Komatsu; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

7.  BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits.

Authors:  Undine E Lang; Rainer Hellweg; Jürgen Gallinat
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

8.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

9.  Identification of pro- and mature brain-derived neurotrophic factor in human saliva.

Authors:  A L Mandel; H Ozdener; V Utermohlen
Journal:  Arch Oral Biol       Date:  2009-05-20       Impact factor: 2.633

10.  Purification of a new neurotrophic factor from mammalian brain.

Authors:  Y A Barde; D Edgar; H Thoenen
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  8 in total

1.  Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms.

Authors:  Jody Corey-Bloom; Alaina M Aikin; Ashley M Gutierrez; Jwan S Nadhem; Taylor L Howell; Elizabeth A Thomas
Journal:  Brain Res       Date:  2017-08-18       Impact factor: 3.252

2.  Initial Observations of Salivary Brain-Derived Neurotrophic Factor Levels in Rett Syndrome.

Authors:  Breanne Byiers; Chantel Barney; Michael Ehrhardt; Angela Panoskaltsis-Mortari; Timothy Feyma; Arthur Beisang; Frank J Symons
Journal:  Pediatr Neurol       Date:  2017-12-08       Impact factor: 3.372

3.  Expression and localization of brain-derived neurotrophic factor (BDNF) mRNA and protein in human submandibular gland.

Authors:  Juri Saruta; Kazuhiro Fujino; Masahiro To; Keiichi Tsukinoki
Journal:  Acta Histochem Cytochem       Date:  2012-06-30       Impact factor: 1.938

4.  The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial.

Authors:  Cay Anderson-Hanley; Nicole M Barcelos; Earl A Zimmerman; Robert W Gillen; Mina Dunnam; Brian D Cohen; Vadim Yerokhin; Kenneth E Miller; David J Hayes; Paul J Arciero; Molly Maloney; Arthur F Kramer
Journal:  Front Aging Neurosci       Date:  2018-05-04       Impact factor: 5.750

5.  Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients.

Authors:  Ashley Gutierrez; Jody Corey-Bloom; Elizabeth A Thomas; Paula Desplats
Journal:  Front Mol Neurosci       Date:  2020-01-23       Impact factor: 5.639

6.  Saliva as a medium to detect and measure biomarkers related to pain.

Authors:  Hajer Jasim; Anders Carlsson; Britt Hedenberg-Magnusson; Bijar Ghafouri; Malin Ernberg
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

7.  The Fear of Pain Questionnaire: psychometric properties of a Brazilian version for adolescents and its relationship with brain-derived neurotrophic factor (BDNF).

Authors:  José Ary Berniger Romariz; Cássio Nonnemacher; Mylena Abreu; Joice Dickel Segabinazi; Janete Shatkoski Bandeira; Gerardo Beltran; Andressa Souza; Iraci Ls Torres; Wolnei Caumo
Journal:  J Pain Res       Date:  2019-08-07       Impact factor: 3.133

8.  Validation of the Brazilian version of the child pain catastrophizing scale and its relationship with a marker of central sensitization.

Authors:  Larissa Schneider; Stela Maris de Jezus Castro; Eliza Saggin Mallman; Cibelle de Abreu Evaldt; Andressa Souza; Josy da Silva Rodrigues; Clarissa Mendanha; Wolnei Caumo; Luciana Cadore Stefani
Journal:  Braz J Anesthesiol       Date:  2021-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.